Prognosis
U.S. Cases Rise 0.4%; California’s Outbreak Easing: Virus Update
This article is for subscribers only.
U.S. health officials offered conflicting estimates of when Americans should expect coronavirus vaccines to be widely available. Preparations are underway to ensure that vaccines will be shipped to administration sites within 24 hours of clearance by federal regulators.
AstraZeneca Plc’s trial remains paused in the U.S. pending a regulatory review of an incident in which a participant became ill. But symptoms probably weren’t related to the shot itself, according to documents sent to participants. Eli Lilly & Co. gained after an experimental antibody treatment showed promising results.